Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | PLG | P00747 | 1/20 | 0.57 |
| ▸ | PLAT | P00750 | 1/20 | 0.57 |
| ▸ | ANPEP | P15144 | 1/20 | 0.57 |
| ▸ | GABRR1 | P24046 | 5/20 | 0.43 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | PEPD | P12955 | 1/20 | 0.42 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.36 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3282964 | 1.00 | LMNA (0.57) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL9504271 | 1.00 | LMNA (0.57) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL30484839 | 1.00 | LMNA (0.57) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL5503262 | 1.00 | LMNA (0.57) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL5503267 | 1.00 | LMNA (0.57) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL9294167 | 0.96 | LMNA (0.57) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL1965494 | 0.87 | LMNA (0.75) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL29954120 | 0.87 | LMNA (0.75) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL5722332 | 0.87 | LMNA (0.75) | LMNAPLGPLATANPEPGABRR1 | |
| SCHEMBL28816390 | 0.87 | LMNA (0.75) | LMNAPLGPLATANPEPGABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| EP-0329105-B1 | MOLECULAR WEIGHT CONTROLLER FOR POLYMERIZATION OF LACTAMS TO POLYAMIDES | BASF Corporation (US) | 1993-07-07 | — | — | EP | claimed |
| US-5006635-A | Monofunctional amine, monofunctional acid, salt of aminoacid, polyamides | BASF CORPORATION (US) | 1991-04-09 | — | — | US | claimed |
| EP-0329105-A2 | Molecular weight controller for polymerization of lactams to polyamides | BASF Corporation (US) | 1989-08-23 | — | — | EP | claimed |
| US-4844834-A | Molecular weight controller for polymerization of lactams to polyamides | BASF CORPORATION (US) | 1989-07-04 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-0329105-B1 | MOLECULAR WEIGHT CONTROLLER FOR POLYMERIZATION OF LACTAMS TO POLYAMIDES | BASF Corporation (US) | 1993-07-07 | — | — | EP | disclosed |
| US-5006635-A | Monofunctional amine, monofunctional acid, salt of aminoacid, polyamides | BASF CORPORATION (US) | 1991-04-09 | — | — | US | disclosed |
| EP-0329105-A2 | Molecular weight controller for polymerization of lactams to polyamides | BASF Corporation (US) | 1989-08-23 | — | — | EP | disclosed |
| US-4844834-A | Molecular weight controller for polymerization of lactams to polyamides | BASF CORPORATION (US) | 1989-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | LMNA 4108/4885PLG 2099/4885PLAT 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.